Search
for
Sort by
Research 271–300 of 1000+
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Polycystic ovary syndrome
- Androgens and androgen receptor action in skin and hair follicles
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Prolactin and the Skin: A Dermatological Perspective on an Ancient Pleiotropic Peptide Hormone
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- Oestrogen receptor evaluation in Pomeranian dogs with hair cycle arrest (alopecia X) on melatonin supplementation
- Topical L‐thyroxine: The Cinderella among hormones waiting to dance on the floor of dermatological therapy?
- Metabolism and skin diseases
- Testosterone Treatment in Women – An Overview
- Hyperandrogenism in a Postmenopausal Woman Secondary to Testosterone Secreting Ovarian Stromal Tumor with Acoustic Schwannoma
- Diagnosis and Management of Infertility due to Anovulation
- Melanocytes and Vitiligo (and Hair Graying)
- Skin manifestations of hyperandrogenism: an update
- Neuroendocrine Controls of Keratin Expression in Human Skin
- General Dermatology
- Primary Generalized Glucocorticoid Resistance or Chrousos Syndrome: Allostasis Through a Mutated Glucocorticoid Receptor
- Delayed Puberty
- No metabolic impact of surgical normalization of hyperandrogenism in postmenopausal women with ovarian androgen-secreting tumours
- Endocrine disorders and hormonal therapy for adolescent acne
- Association Between 5-Alpha Reductase Inhibitor Use and The Risk of Depression: A Meta-Analysis.
- Menopause
- A Practitioner's Guide to Hair Loss Part 1—History, Biology, Genetics, Prevention, Conventional Treatments, and Herbals
- Updates on Hirsutism: A Narrative Review
- Melatonin in the skin: synthesis, metabolism and functions
- Novel inhibitors of 5α-reductase
- A STUDY ON CUTANEOUS MANIFESTATIONS OF HYPOTHYROIDISM IN A TERTIARY HOSPITAL IN SOUTH INDIA
- Neuroactive Steroids and Ethanol Exposure: Relevance to Ethanol Sensitivity and Alcohol Use Disorders Risk
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome